Gypenosides (Gyps) are triterpenoid saponins contained in an extract from Gynostemma pentaphyllum Makino and reported to induce apoptosis in human hepatoma cells through Ca 2 + -implicated endoplasmic reticulum (ER) stress and mitochondria-dependent pathways. The mechanism underlying the Gyp-increased intracellular Ca 2 + channel (SOC) inhibitor 2-aminoethoxydiphenyl borate (2-APB), and ER Ca 2 + -release-antagonist 3,4,5-trimethoxybenzoic acid 8-(diethylamino) octyl ester (TMB-8). The strongest inhibitory effect was observed with TMB-8. EGTA, 2-APB, and TMB-8 also protected against Gyp-induced apoptosis in HepG2 cells. The combination of 2-APB and TMB-8 almost completely abolished the Gyp-induced Ca 2 + response and apoptosis. In contrast, the sarco/endoplasmic-reticulum-Ca 2 + -ATPase (SERCA) inhibitor thapsigargin slightly elevated Gyp-induced [Ca 2 + ] i increase and apoptosis in HepG2 cells. Exposure to 300 lg/mL Gyp for 24 hours upregulated protein levels of inositol 1,4,5-trisphosphate receptor and SOC and downregulated that of SERCA for at least 72 hours. Thus, Gyp-induced increase in [Ca 2 + ] i level and consequent apoptosis in HepG2 cells may be mainly due to enhanced Ca 2 + release from ER stores and increased store-operated Ca 2 + entry.